BrightSpring (BTSG) insider exercises options and sells 260,000 shares
Rhea-AI Filing Summary
BrightSpring Health Services director and officer Jon B. Rousseau reported a mix of option exercises and share sales involving 260,000 shares each way. He exercised stock options to acquire 260,000 shares of common stock at $6.37 per share, then sold 260,000 shares at $58.75 per share in transactions that include sales by The Margaret Rousseau Children Trust under a registered public offering that closed on June 5, 2026. After these transactions, Rousseau holds 1,194,503 shares of common stock directly and has indirect interests through family trusts, including 369,763 common shares and fully vested stock options linked to 377,602 underlying shares at a $6.37 exercise price expiring on October 16, 2029. Rousseau disclaims beneficial ownership of the indirectly held securities except to the extent of his pecuniary interest.
Positive
- None.
Negative
- None.
Insights
Rousseau executes an exercise-and-sell pattern, with a net sale of 260,000 shares while retaining sizable direct and option holdings.
The filing shows Jon B. Rousseau exercising stock options for 260,000 shares at an exercise price of $6.37 and selling 260,000 shares at $58.75. Parts of these transactions run through The Margaret Rousseau Children Trust under a registered public offering that closed on June 5, 2026, and others are from his direct holdings.
Despite the net-sell direction of 260,000 shares, Rousseau still directly holds 1,194,503 common shares and retains fully vested options indirectly over 377,602 underlying shares at a $6.37 strike, expiring on October 16, 2029. He disclaims beneficial ownership of the indirect positions beyond his pecuniary interest, so the economic exposure is partly through family trusts rather than solely personal holdings.
The pattern resembles a structured liquidity event rather than a full exit, given the remaining equity and option exposure. Future filings may clarify how his total position evolves as options approach the 2029 expiration and whether additional sales by the associated trusts occur under similar public offerings.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Options (Right to Buy) | 130,000 | $0.00 | -- |
| Exercise | Stock Options (Right to Buy) | 130,000 | $0.00 | -- |
| Exercise | Common Stock | 130,000 | $6.37 | $828K |
| Sale | Common Stock | 130,000 | $58.75 | $7.64M |
| Exercise | Common Stock | 130,000 | $6.37 | $828K |
| Sale | Common Stock | 130,000 | $58.75 | $7.64M |
| holding | Stock Options (Right to Buy) | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- These shares of the Issuer's common stock were sold by the Reporting Person pursuant to a registered public offering that closed on June 5, 2026, at a price of $58.75, before deducting underwriting discounts and commissions. The Reporting Person states that this filing shall not be an admission that the Reporting Person is the beneficial owner of any of the securities reported herein as indirectly owned, and the Reporting Person disclaims beneficial ownership of such securities except to the extent of the Reporting Person's pecuniary interest therein. These options are fully vested.